Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis

ABSTRACT: A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis

PROVIDER: PRJEB21353 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2019990_1.fastq.gz	Fastqsanger.gz
	ERR2019990_2.fastq.gz	Fastqsanger.gz
	ERR2019991_1.fastq.gz	Fastqsanger.gz
	ERR2019991_2.fastq.gz	Fastqsanger.gz
	ERR2019992_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis.

Project description:Cystic Fibrosis (CF) and its treatment result in an altered gut microbiota composition compared to non-CF controls. However, the impact of this on gut microbiota functionality has not been extensively characterised. Our aim was to conduct a proof-of-principle study to investigate if measurable changes in gut microbiota functionality occur in adult CF patients compared to controls. Metagenomic DNA was extracted from faecal samples from six CF patients and six non-CF controls and shotgun metagenomic sequencing was performed on the MiSeq platform. Metabolomic analysis using gas chromatography-mass spectrometry was conducted on faecal water. The gut microbiota of the CF group was significantly different compared to the non-CF controls, with significantly increased Firmicutes and decreased Bacteroidetes. Functionality was altered, with higher pathway abundances and gene families involved in lipid (e.g. PWY 6284 unsaturated fatty acid biosynthesis (p = 0.016)) and xenobiotic metabolism (e.g. PWY-5430 meta-cleavage pathway of aromatic compounds (p = 0.004)) in CF patients compared to the controls. Significant differences in metabolites occurred between the two groups. This proof-of-principle study demonstrates that measurable changes in gut microbiota functionality occur in CF patients compared to controls. Larger studies are thus needed to interrogate this further.

| S-EPMC5532234 | biostudies-literature

The Impact of Respiratory Microbiome of Adults with Cystic Fibrosis

Project description:The Impact of Viral Respiratory Infection on the Respiratory Microbiome of Adults with Cystic Fibrosis

| PRJEB11908 | ENA

Metaproteomic profiling of induced and spontaneous sputum samples from cystic fibrosis patients

Project description:Application of a mass spectrometry -based approach to assess the lung microbiota composition and the associated metaproteomic functionality of subjects with cystic fibrosis

2023-02-04 | PXD034628 | Pride

Whole blood gene expression to predict susceptibility to nontuberculous mycobacterial pulmonary disease in adults with cystic fibrosis

Project description:Background: Patients with cystic fibrosis (CF) have an elevated lifetime risk of infection and disease caused by nontuberculous mycobacteria (NTM). Currently, there is no method to predict whether patients with cystic fibrosis will develop disease related to non-tuberculous mycobacteria. In non cystic fibrosis populations, several genetic susceptibility factors have been described. In this study, we examined whether patients with cystic fibrosis demonstrate a similar pattern of genetic susceptibility and explored host immune-related biomarkers predictive of NTM pulmonary disease (NTM-PD). Methods: We evaluated whole blood gene expression using bulk RNA-seq in a cohort of CF patients at the time of first isolation of NTM. Differential gene expression was compared in patients who did (n = 12) vs. did not (n= 30) develop NTM-PD following first NTM growth. Results: No differences in demographics or composition of white blood cell sample populations at the time of sample collection were identified between groups. There were no significant differences in the expression of genes previously reported to confer susceptibility to NTM-PD in non-CF populations. However, CF patients who went on to develop NTM-PD had higher expression of genes involved in the interferon ( and ), tumor necrosis factor, and IL6 STAT3 JAK pathways. Conclusion: Patients with CF who develop NTM-PD have increased expression of genes involved in innate immunity, in contrast to non-CF populations where these responses seem to be suppressed.

2022-12-14 | GSE205161 | GEO

Colorectal Cancer Screening in Cystic Fibrosis

Project description:This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).

| 2726863 | ecrin-mdr-crc

Pilot for BENEFIT (rice)

Project description:Pilot dietary intervention with heat-stabilized rice bran modulates stool microbiota and metabolites in healthy adults

| PRJEB8075 | ENA

Proteomics analysis of cystic fluid from human cystic papillary thyroid carcinoma

Project description:Here we have performed quantitative and qualitative profiling of the proteome of cystic fluid from human cystic papillary thyroid carcinoma with the aim to identify specific proteins and pathways involved in cystic fluid from human cystic papillary carcinoma, as well as possible diagnostic markers.

2015-05-20 | PXD000996 | Pride

Chlamydia trachomatis pilot

Project description:Chlamydia trachomatis pilot

| PRJEB2214 | ENA

Mycobacterium tuberculosis pilot

Project description:Mycobacterium tuberculosis pilot

| PRJEB2221 | ENA

Illinois EBP Pilot

Project description:Illinois EBP Pilot

| PRJNA844590 | ENA